Cell surface expression level variation between two common human leukocyte antigen alleles, HLA-A2 and HLA-B8, is dependent on the structure of the C terminal part of the alpha 2 and the alpha 3 domains

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Dellgren, Christoffer ^a   Nehlin, Jan O ^a   Barington, Torben ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA A2 ANTIGEN; HLA B8 ANTIGEN; HYBRID PROTEIN; HLA A3 ANTIGEN; HLA B7 ANTIGEN; MESSENGER RNA;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; HLA A2 GENE; HLA B8 GENE; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RNA TRANSLATION; START CODON; TRANSCRIPTION REGULATION; UPREGULATION; ALLELE; AMINO ACID SEQUENCE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PLASMID; PROTEIN TERTIARY STRUCTURE;

ALLELES; AMINO ACID SEQUENCE; GENE EXPRESSION REGULATION; HEK293 CELLS; HISTOCOMPATIBILITY TESTING; HLA-A2 ANTIGEN; HLA-A3 ANTIGEN; HLA-B7 ANTIGEN; HLA-B8 ANTIGEN; HUMANS; INTERFERON-GAMMA; MOLECULAR SEQUENCE DATA; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; TRANSFECTION;

EID: 84942456313     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135385     Document Type: Article

References (33)

1. Klein MR, van der Burg SH, Hovenkamp E, Holwerda AM, Drijfhout JW, Melief CJ, et al. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag-and RT-specific cytotoxic T lymphocyte responses. J Gen Virol. 1998; 79 (Pt 9):2191-201. Epub 1998/09/25. PMID: 9747728.
2. Gao X, Nelson GW, Karacki P, Martin MP, Phair J, Kaslow R, et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med. 2001; 344(22):1668-75. Epub 2001/06/02. doi: 10.1056/nejm200105313442203 PMID: 11386265.
3. Gillespie GM, Kaul R, Dong T, Yang HB, Rostron T, Bwayo JJ, et al. Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B∗57. AIDS. 2002; 16(7):961-72. Epub 2002/04/16. PMID: 11953462.
4. Carrington M, O'Brien SJ. The influence of HLA genotype on AIDS. Annu Rev Med. 2003; 54:535-51. Epub 2003/01/15. doi: 10.1146/annurev.med.54.101601.152346 PMID: 12525683.
5. Bailey JR, Williams TM, Siliciano RF, Blankson JN. Maintenance of viral suppression in HIV-1-infected HLA-B∗57+ elite suppressors despite CTL escape mutations. J Exp Med. 2006; 203(5):1357-69. Epub 2006/05/10. doi: 10.1084/jem.20052319 PMID: 16682496; PubMed Central PMCID: PMCPmc2121215.
6. Bukur J, Jasinski S, Seliger B. The role of classical and non-classical HLA class I antigens in human tumors. Semin Cancer Biol. 2012; 22(4):350-8. Epub 2012/04/03. doi: 10.1016/j.semcancer.2012.03. 003 PMID: 22465194.
7. Maeurer MJ, Gollin SM, Martin D, Swaney W, Bryant J, Castelli C, et al. Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen. J Clin Invest. 1996; 98(7):1633-41. Epub 1996/10/01. doi: 10.1172/jci118958 PMID: 8833913; PubMed Central PMCID: PMCPmc507597.
8. Maeurer MJ, Gollin SM, Storkus WJ, Swaney W, Karbach J, Martin D, et al. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6. Clin Cancer Res. 1996; 2(4):641-52. Epub 1996/04/01. PMID: 9816214.
9. Hiraki A, Fujii N, Murakami T, Kiura K, Aoe K, Yamane H, et al. High frequency of allele-specific downregulation of HLA class I expression in lung cancer cell lines. Anticancer Res. 2004; 24(3a):1525-8. Epub 2004/07/28. PMID: 15274319.
10. Apps R, Qi Y, Carlson JM, Chen H, Gao X, Thomas R, et al. Influence of HLA-C expression level on HIV control. Science. 2013; 340(6128):87-91. doi: 10.1126/science.1232685 PMID: 23559252; PubMed Central PMCID: PMC3784322.
11. Petersdorf EW, Gooley TA, Malkki M, Bacigalupo AP, Cesbron A, Du Toit E, et al. HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation. Blood. 2014. doi: 10.1182/blood-2014-09-599969 PMID: 25323824.
12. Fleming KA, McMichael A, Morton JA, Woods J, McGee JO. Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer. J Clin Pathol. 1981; 34(7):779-84. Epub 1981/07/01. PMID: 7021603; PubMed Central PMCID: PMCPmc493815.
13. Joly E, Mucke L, Oldstone MB. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science. 1991; 253(5025):1283-5. Epub 1991/09/13. PMID: 1891717.
14. Isa A, Nehlin JO, Sabir HJ, Andersen TE, Gaster M, Kassem M, et al. Impaired cell surface expression of HLA-B antigens on mesenchymal stem cells and muscle cell progenitors. PLoS One. 2010; 5(5): e10900. doi: 10.1371/journal.pone.0010900 PMID: 20531935; PubMed Central PMCID: PMC2878340.
15. Sabir HJ, Nehlin JO, Qanie D, Harkness L, Prokhorova TA, Blagoev B, et al. Separate developmental programs for HLA-A and-B cell surface expression during differentiation from embryonic stem cells to lymphocytes, adipocytes and osteoblasts. PLoS One. 2013; 8(1):e54366. doi: 10.1371/journal.pone. 0054366 PMID: 23349864; PubMed Central PMCID: PMC3548781.
16. Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SI, et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol. 2002; 20(6):592-6. Epub 2002/06/04. doi: 10.1038/nbt0602-592 PMID: 12042863.
17. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol. 1987; 7(1):379-87. Epub 1987/01/01. PMID: 3031469; PubMed Central PMCID: PMCPmc365079.
18. Vogel R, Al-Daccak R, Drews O, Alonzeau J, Mester G, Charron D, et al. Mass spectrometry reveals changes in MHC I antigen presentation after lentivector expression of a gene regulation system. Mol Ther Nucleic Acids. 2013; 2:e75. Epub 2013/02/14. doi: 10.1038/mtna.2013.3 PMID: 23403517; PubMed Central PMCID: PMCPmc3586803.
19. De Vito LD, Mason BP, Jankowska-Gan E, Hogan KT, Guo JW, Lutz CT, et al. Epitope fine specificity of human anti-HLA-A2 antibodies. Identification of four epitopes including a haptenlike epitope on HLAA2 at lysine 127. Hum Immunol. 1993; 37(3):165-77. Epub 1993/07/01. PMID: 7503972.
20. Garstka M, Borchert B, Al-Balushi M, Praveen PV, Kuhl N, Majoul I, et al. Peptide-receptive major histocompatibility complex class I molecules cycle between endoplasmic reticulum and cis-Golgi in wildtype lymphocytes. J Biol Chem. 2007; 282(42):30680-90. doi: 10.1074/jbc.M701721200 PMID: 17656363.
21. Park B, Lee S, Kim E, Ahn K. A Single Polymorphic Residue Within the Peptide-Binding Cleft of MHC Class I Molecules Determines Spectrum of Tapasin Dependence. The Journal of Immunology. 2003; 170(2):961-8. doi: 10.4049/jimmunol.170.2.961 PMID: 12517962
22. Zarling AL, Luckey CJ, Marto JA, White FM, Brame CJ, Evans AM, et al. Tapasin Is a Facilitator, Not an Editor, of Class I MHC Peptide Binding. The Journal of Immunology. 2003; 171(10):5287-95. doi: 10. 4049/jimmunol.171.10.5287 PMID: 14607930
23. Peh CA, Burrows SR, Barnden M, Khanna R, Cresswell P, Moss DJ, et al. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity. 1998; 8(5):531-42. Epub 1998/06/10. PMID: 9620674.
24. Ortmann B, Copeman J, Lehner PJ, Sadasivan B, Herberg JA, Grandea AG, et al. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science. 1997; 277 (5330):1306-9. Epub 1997/08/29. PMID: 9271576.
25. Harris MR, Lybarger L, Myers NB, Hilbert C, Solheim JC, Hansen TH, et al. Interactions of HLA-B27 with the peptide loading complex as revealed by heavy chain mutations. Int Immunol. 2001; 13 (10):1275-82. Epub 2001/10/03. PMID: 11581172.
26. Lehner PJ, Surman MJ, Cresswell P. Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line.220. Immunity. 1998; 8(2):221-31. Epub 1998/03/10. PMID: 9492003.
27. Reeves E, Colebatch-Bourn A, Elliott T, Edwards CJ, James E. Functionally distinct ERAP1 allotype combinations distinguish individuals with Ankylosing Spondylitis. Proc Natl Acad Sci U S A. 2014; 111 (49):17594-9. Epub 2014/11/26. doi: 10.1073/pnas.1408882111 PMID: 25422414; PubMed Central PMCID: PMCPmc4267330.
28. Spiliotis ET, Manley H, Osorio M, Zuniga MC, Edidin M. Selective export of MHC class I molecules from the ER after their dissociation from TAP. Immunity. 2000; 13(6):841-51. Epub 2001/02/13. PMID: 11163199.
29. Cho S, Ryoo J, Jun Y, Ahn K. Receptor-mediated ER export of human MHC class I molecules is regulated by the C-terminal single amino acid. Traffic (Copenhagen, Denmark). 2011; 12(1):42-55. doi: 10. 1111/j.1600-0854.2010.01132.x PMID: 20946353.
30. Quistgaard EM, Low C, Moberg P, Guettou F, Maddi K, Nordlund P. Structural and biophysical characterization of the cytoplasmic domains of human BAP29 and BAP31. PLoS One. 2013; 8(8):e71111. doi: 10.1371/journal.pone.0071111 PMID: 23967155; PubMed Central PMCID: PMC3742741.
31. Carreno BM, Solheim JC, Harris M, Stroynowski I, Connolly JM, Hansen TH. TAP associates with a unique class I conformation, whereas calnexin associates with multiple class I forms in mouse and man. J Immunol. 1995; 155(10):4726-33. Epub 1995/11/15. PMID: 7594473.
32. Kulig K, Nandi D, Bacik I, Monaco JJ, Vukmanovic S. Physical and functional association of the major histocompatibility complex class I heavy chain alpha3 domain with the transporter associated with antigen processing. J Exp Med. 1998; 187(6):865-74. Epub 1998/04/04. PMID: 9500789; PubMed Central PMCID: PMCPmc2212190.
33. Suh WK, Derby MA, Cohen-Doyle MF, Schoenhals GJ, Fruh K, Berzofsky JA, et al. Interaction of murine MHC class I molecules with tapasin and TAP enhances peptide loading and involves the heavy chain alpha3 domain. J Immunol. 1999; 162(3):1530-40. Epub 1999/02/11. PMID: 9973410.